Ying-Hua Huang

Dr. Ying-Hua Huang

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TWTe-Ju Wu
Te-Ju Wu
CTChia-Ling Tsai
Chia-Ling Tsai
QGQuan-Ze Gao
Quan-Ze Gao
YCyueh-peng Chen
yueh-peng Chen
CKChang-Fu Kuo
Chang-Fu Kuo
YHYing-Hua Huang
Ying-Hua Huang
Background: This study aimed to reveal the efficacy of the artificial intelligence (AI)-assisted dental age (DA) assessment in identifying the characteristics of growth delay (GD) in children. Methods: The panoramic films matching the inclusion criteria were collected for the AI model training to establish the population-based DA standard. Subsequently, the DA of the validation dataset of the healthy children and the images of the GD children were assessed by both the conventional methods and the AI-assisted standards. The efficacy of all the studied modalities was compared by the paired sample t-test. Results: The AI-assisted standards can provide much more accurate chronological age (CA) predictions with mean errors of less than 0.05 years, while the traditional methods presented overestimated results in both genders. For the GD children, the convolutional neural network (CNN) revealed the delayed DA in GD children of both genders, while the machine learning models presented so only in the GD boys. Conclusion: The AI-assisted DA assessments help overcome the long-standing populational limitation observed in traditional methods. The image feature extraction of the CNN models provided the best efficacy to reveal the nature of delayed DA in GD children of both genders.

Verified
Journal Article
Open access
PDF file
YHYing-Hua Huang
Ying-Hua Huang
You-Lin TainYou-Lin Tain
You-Lin Tain
CHChien-Ning Hsu
Chien-Ning Hsu
Metabolic syndrome (MetS) is an extremely prevalent complex trait and it can originate in early life. This concept is now being termed the developmental origins of health and disease (DOHaD). Increasing evidence supports that disturbance of gut microbiota influences various risk factors of MetS. The DOHaD theory provides an innovative strategy to prevent MetS through early intervention (i.e., reprogramming). In this review, we summarize the existing literature that supports how environmental cues induced MetS of developmental origins and the interplay between gut microbiota and other fundamental underlying mechanisms. We also present an overview of experimental animal models addressing implementation of gut microbiota-targeted reprogramming interventions to avert the programming of MetS. Even with growing evidence from animal studies supporting the uses of gut microbiota-targeted therapies start before birth to protect against MetS of developmental origins, their effects on pregnant women are still unknown and these results require further clinical translation.

15 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TCTe-Chuan Chen
Te-Chuan Chen
YTYi-Ju Tseng
Yi-Ju Tseng
YHYing-Hua Huang
Ying-Hua Huang
HLHsi-Yun Liu
Hsi-Yun Liu
YWYi-Hua Wu
Yi-Hua Wu
YLYing-Jui Lin
Ying-Jui Lin
Background: Infective endocarditis (IE) is an important cause of morbidity and mortality in pediatric patients with heart disease. Little literature has explored differences in the presentation of endocarditis in children with and without heart disease. This study aimed to compare the clinical outcomes and determine the risk of in-hospital death in the study population. Methods: Data were retrospectively collected from 2001 to 2019 from the Chang Gung Research Database (CGRD), which is the largest collection of multi-institutional electronic medical records in Taiwan. Children aged 0–20 years with IE were enrolled. We extracted and analyzed the demographic and clinical features, complications, microbiological information, and outcomes of each patient. Results: Of the 208 patients with IE, 114 had heart disease and 94 did not. Compared to those without heart disease, more streptococcal infections (19.3% vs. 2.1%, p < 0.001) and cardiac complications (29.8% vs. 6.4%, p < 0.001) were observed in patients with heart disease. Although patients with heart disease underwent valve surgery more frequently (43.9% vs. 8.5%, p < 0.001) and had longer hospital stays (28.5 vs. 12.5, p = 0.021), their mortality was lower than that of those without heart disease (3.5% vs. 10.6%, p = 0.041). Thrombocytopenia was independent risk factor for in-hospital mortality in pediatric patients with IE (OR = 6.56, 95% CI: 1.43–40.37). Conclusion: Among pediatric patients diagnosed with IE, microbiological and clinical features differed between those with and without heart disease. Platelet counts can be used as a risk factor for in-hospital mortality in pediatric patients with IE.

30 September 2026 in JBMR Plus
Verified
Journal Article
Open access
SLSHIH-YAO LIU
SHIH-YAO LIU
YTYi-Ching Tung
Yi-Ching Tung
CHChia-Chi Hsu
Chia-Chi Hsu
YKYu-Yuan Ke
Yu-Yuan Ke
YHYing-Hua Huang
Ying-Hua Huang
WTWen-Yu Tsai
Wen-Yu Tsai
X-linked hypophosphatemia (XLH) is a rare, lifelong disorder of renal phosphate wasting that typically presents in childhood with skeletal deformities, growth retardation, and functional impairment, although these features may be less pronounced in milder cases. The disease persists into adulthood with chronic pain, mobility limitations, and psychosocial challenges. While pediatric XLH has been well described internationally, the lifelong disease journey in Taiwan remains poorly characterized. We conducted a multicenter qualitative study using semi-structured, in-depth interviews between July 2024 and January 2025 at 3 major medical centers, enrolling 15 patients with a clinical diagnosis of XLH (genetically confirmed in a subset): 8 pediatric patients (aged ≥5 yr) interviewed with caregivers and 7 adults interviewed independently. Interviews (~60 min) explored diagnostic pathways, treatment experiences, disease burden, and support needs; transcripts were analyzed thematically. Participants commonly reported delayed or missed diagnosis, with early symptoms such as bowed legs and short stature often misattributed to nutritional or growth-related issues, leading to late referral to specialist care. Oral phosphate supplementation and active vitamin D (Pi/D) were the predominant treatments; however, frequent dosing, poor palatability, and gastrointestinal side effects contributed to low adherence. Many adults had discontinued therapy, and 12 patients underwent corrective limb surgery, mainly during childhood or adolescence. Across the life course, patients experienced chronic bone pain, reduced mobility, and insufficiency fractures, as well as psychosocial burdens, including anxiety, low self-esteem, social withdrawal, and caregiver stress, often compounded by guilt related to hereditary transmission. Patients and caregivers emphasized unmet needs in disease education, transition from pediatric to adult care, peer support, and interest in novel therapies, such as burosumab. These findings highlight substantial lifelong disease burden among patients with XLH in Taiwan and underscore the need for earlier diagnosis, multidisciplinary care, and improved access to emerging therapies.